Paroxysmal nocturnal hemoglobinuria or other hemolytic diseases are treating using a compound which binds to or otherwise blocks the generation and/or the activity of one or more complement components, such as, for example, a complement-inhibiting antibody.
申请公布号
WO2005074607(A3)
申请公布日期
2006.09.14
申请号
WO2005US03225
申请日期
2005.02.03
申请人
ALEXION PHARMACEUTICALS, INC.;BELL, LEONARD;ROTHER, RUSSELL, P.
